QResearch
QResearch is a large consolidated database of anonymised health records from general practitioners in the United Kingdom. It was established in 2002 by the University of Nottingham and EMIS Health, a supplier of electronic patient record systems to general practices. The database includes data from more than 32 million patients, and is used for a variety of research projects, including epidemiology, health services research, and randomised controlled trials.
Overview[edit | edit source]
QResearch is a not-for-profit collaboration between the University of Nottingham and EMIS Health. The database was established to provide a resource for researchers in the field of health and medicine. It contains anonymised health records from more than 32 million patients in the UK, making it one of the largest databases of its kind in the world.
The data in QResearch is collected from general practices that use the EMIS Web clinical system. This includes information on patient demographics, diagnoses, prescriptions, laboratory test results, and referrals to specialist services. The data is updated on a monthly basis, and all records are anonymised to protect patient confidentiality.
Uses[edit | edit source]
QResearch is used for a wide range of research projects. These include studies in epidemiology, health services research, and randomised controlled trials. The database has been used to investigate a variety of health conditions, including cardiovascular disease, diabetes, cancer, and mental health disorders.
In addition to research, QResearch is also used for public health surveillance and health policy development. The database provides a valuable resource for monitoring trends in disease prevalence and treatment, and for evaluating the impact of health policies and interventions.
Access[edit | edit source]
Access to QResearch is granted on a project-by-project basis, and is subject to approval by the QResearch Scientific Committee. Researchers must submit a proposal outlining the aims and methods of their study, and must agree to comply with all relevant ethical and data protection regulations.
See also[edit | edit source]
References[edit | edit source]
| QResearch Resources | |
|---|---|
|
 |
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
